Tumour necrosis factor (TNF)α -308 G/G promoter polymorphism and TNFα levels correlate with a better response to adalimumab in patients with rheumatoid arthritis.

Autor: Cuchacovich, M.1,2 (AUTHOR) mcuchaco@yahoo.com, Soto, L.1 (AUTHOR), Edwardes, M.3 (AUTHOR), Gutierrez, M.4 (AUTHOR), Llanos, C.1 (AUTHOR), Pacheco, D.5 (AUTHOR), Sabugo, F.1 (AUTHOR), Alamo, M.6 (AUTHOR), Fuentealba, C.5 (AUTHOR), Villanueva, L.7 (AUTHOR), Gatica, H.1 (AUTHOR), Schiattino, I.8 (AUTHOR), Salazar, L.9 (AUTHOR), Catalan, D.9 (AUTHOR), Valenzuela, O.1 (AUTHOR), Salazar‐Onfray, F.9 (AUTHOR), Aguillón, J. C.9 (AUTHOR)
Zdroj: Scandinavian Journal of Rheumatology. Nov/Dec2006, Vol. 35 Issue 6, p435-440. 6p. 4 Charts, 2 Graphs.
Databáze: Academic Search Ultimate
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje